SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: John McCarthy who wrote (1189)4/29/2003 5:30:07 PM
From: JMarcus  Read Replies (1) | Respond to of 1494
 
FRX may be cool, but statistically there is a strong correlation in the biotech sector (and probably others too) between good news and stock advances shortly before the public announcement of the news.

I checked with my oncologist friend, but he wasn't familiar with NVGN either. Sorry.

Marc



To: John McCarthy who wrote (1189)5/2/2003 12:01:35 PM
From: Biomaven  Respond to of 1494
 
(OT - NVGN)

John,

You piqued my curiosity enough to take a look at the new article on phenoxodiol. Very early, but also interesting. I will post the abstract over on the valuation thread to spare this thread.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News